BHC(SH:600721) Xin Lang Cai Jing·2025-08-22 02:11Core Insights - Baihua Pharmaceutical (600721.SH) reported a total operating revenue of 202 million yuan for the first half of 2025, an increase of 5.78 million yuan compared to the same period last year, marking a 2.95% year-on-year growth and achieving five consecutive years of revenue growth [1] - The net profit attributable to shareholders reached 25.48 million yuan, up by 2.82 million yuan from the same period last year, reflecting a 12.45% year-on-year increase and three consecutive years of profit growth [1] - The company experienced a net cash outflow from operating activities of 4.44 million yuan [1] Financial Performance - The latest debt-to-asset ratio stands at 29.66%, a decrease of 0.79 percentage points from the previous quarter and a reduction of 4.45 percentage points compared to the same period last year [3] - The gross profit margin is reported at 49.40%, an increase of 1.65 percentage points year-on-year, achieving five consecutive years of growth [4] - The return on equity (ROE) is 3.24%, up by 0.15 percentage points from the same period last year [4] - The diluted earnings per share (EPS) is 0.07 yuan, an increase of 0.01 yuan year-on-year, reflecting an 11.62% growth and three consecutive years of increase [4] - The total asset turnover ratio is 0.18 times, remaining stable compared to the same period last year, with a year-on-year increase of 0.33% over two consecutive years [4] - The inventory turnover ratio is 1.10 times, an increase of 0.28 times year-on-year, achieving a 34.94% growth and five consecutive years of increase [4] Shareholder Structure - The number of shareholders is reported at 30,000, with the top ten shareholders holding a total of 137 million shares, accounting for 35.76% of the total share capital [4] - The top shareholders include: 1. Mi Zaiqi - 8.99% 2. Mi Enhua - 6.70% 3. Yang Xiaoling - 5.00% 4. Xinjiang Xinong Modern Investment Development Co., Ltd. - 4.36% 5. Li Jiancheng - 3.90% 6. Zhang Desheng - 2.12% 7. Ningbo Meishan Free Trade Port Area Daokang Xiangyun Investment Partnership (Limited Partnership) - 1.57% 8. Xinjiang Production and Construction Corps Investment Co., Ltd. - 1.16% 9. Shanghai Jiaqi Asset Management Center (Limited Partnership) - 1.00% 10. Xinjiang Bingshe Material Management Co., Ltd. - 0.93% [4]